SK bioscience Co.,Ltd. (KRX:302440)
South Korea
· Delayed Price · Currency is KRW 40,200
+1,400 (3.61%)
At close: May 8, 2025, 3:30 PM KST
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 3.16 trillion as of May 12, 2025. Its market cap has decreased by -31.60% in one year.
Market Cap
3.16T
Enterprise Value
2.61T
Revenue
267.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
40,200.00
Market Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 3.16T, a decrease of -75.57%. That is a compound annual growth rate of -28.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 3,158.28B | -20.02% |
| Dec 30, 2024 | 3,948.70B | -28.57% |
| Dec 28, 2023 | 5,528.45B | -2.04% |
| Dec 29, 2022 | 5,643.63B | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.02T |
| Celltrion | 33.69T |
| ALTEOGEN | 18.39T |
| Yuhan | 8,026.78B |
| HLB Co., Ltd. | 7,581.42B |
| SK Biopharmaceuticals | 7,079.52B |
| PharmaResearch | 4,171.44B |
| Peptron | 3,872.02B |